NO20005141L - Streptokokkpreparat - Google Patents

Streptokokkpreparat

Info

Publication number
NO20005141L
NO20005141L NO20005141A NO20005141A NO20005141L NO 20005141 L NO20005141 L NO 20005141L NO 20005141 A NO20005141 A NO 20005141A NO 20005141 A NO20005141 A NO 20005141A NO 20005141 L NO20005141 L NO 20005141L
Authority
NO
Norway
Prior art keywords
accession number
streptococcus
under accession
number ncimb
inflammation
Prior art date
Application number
NO20005141A
Other languages
English (en)
Other versions
NO20005141D0 (no
Inventor
Eva Grahn Haakansson
Kristian Roos
Stig Holm
Original Assignee
Bacterum Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bacterum Ab filed Critical Bacterum Ab
Publication of NO20005141D0 publication Critical patent/NO20005141D0/no
Publication of NO20005141L publication Critical patent/NO20005141L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/16—Otologicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Farmasøytisk preparat til forebygging og/eller behandling av akutt otitis media (betennelse i øret) og otitis media (betennelse i mellomøret) inneholdende minst én av mikroorganismestammene Streptococcus sanguis under aksesjonsnummer NCIMB 40104, Streptococcus sanguis under aksesjonsnummer NCIMB 40873, Streptococcus oralis under aksesjonsnummer NCIMB 40875, Streptococcus oralis under aksesjonsnummer NCIMB 4087'6 og Streptococcus mitis under aksesjonsnummer NCIMB 40874, og eventuelt andre alfa-streptokokkstammer som har stort sett samme kapasitet for inhibering av Haemophilus influenzae, Streptococcus pneumoniae og Moraxella catharralis, i et farmasøytisk akseptabelt medium hvori mikroorganismestammene bibeholder sin levedyktighet.
NO20005141A 1998-04-17 2000-10-13 Streptokokkpreparat NO20005141L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE9801337A SE511648C2 (sv) 1998-04-17 1998-04-17 Streptokockpreparat för behandling av öroninflammation
PCT/SE1999/000608 WO1999053932A1 (en) 1998-04-17 1999-04-16 Streptococcus preparation

Publications (2)

Publication Number Publication Date
NO20005141D0 NO20005141D0 (no) 2000-10-13
NO20005141L true NO20005141L (no) 2000-12-14

Family

ID=20410988

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20005141A NO20005141L (no) 1998-04-17 2000-10-13 Streptokokkpreparat

Country Status (11)

Country Link
EP (1) EP1071437A1 (no)
JP (1) JP2002512196A (no)
AU (1) AU4177799A (no)
CA (1) CA2325805A1 (no)
ID (1) ID26655A (no)
IL (1) IL138958A0 (no)
IS (1) IS5661A (no)
NO (1) NO20005141L (no)
PL (1) PL343547A1 (no)
SE (1) SE511648C2 (no)
WO (1) WO1999053932A1 (no)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20060258596A1 (en) * 2003-02-14 2006-11-16 Walsh Timothy R Antimicrobial agents
PL2349295T3 (pl) 2008-11-17 2017-06-30 Winclove Holding B.V. Preparat farmaceutyczny zawierający kombinację szczepów paciorkowców i szczepów lactobacillus
FR2999601B1 (fr) 2012-12-17 2015-01-30 Urgo Lab Methode pour prevenir et/ou traiter les infections, colonisations ou maladies liees a staphylococcus aureus, pseudomonas aeruginosa, streptococcus pyogenes, enterococcus faecium, enterobacter cloacae, proteus mirabilis et/ou bacteroides fragilis
PL3015109T3 (pl) * 2014-10-28 2020-04-30 D.M.G. Italia Srl Bariera biologiczna z simetikonem do zastosowania w leczeniu zakażeń nosowo-gardłowo-przewodowych
CN119464165B (zh) * 2025-01-16 2026-02-24 中日友好医院(中日友好临床医学研究所) 口腔链球菌zrsor-5及其相关产品、方法及应用

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH633188A5 (fr) * 1978-05-26 1982-11-30 Om Laboratoires Sa Medicament contre des maladies infectieuses des voies respiratoires.
SE463349B (sv) * 1989-02-15 1990-11-12 Grahn Eva E Farmaceutiskt preparat foer profylax mot och/eller behandling av beta-streptokockinducerad tonsillit

Also Published As

Publication number Publication date
SE9801337L (sv) 1999-10-18
CA2325805A1 (en) 1999-10-28
AU4177799A (en) 1999-11-08
JP2002512196A (ja) 2002-04-23
ID26655A (id) 2001-01-25
EP1071437A1 (en) 2001-01-31
IL138958A0 (en) 2001-11-25
NO20005141D0 (no) 2000-10-13
PL343547A1 (en) 2001-08-27
SE511648C2 (sv) 1999-11-01
WO1999053932A1 (en) 1999-10-28
IS5661A (is) 2000-10-13
SE9801337D0 (sv) 1998-04-17

Similar Documents

Publication Publication Date Title
Lavollay et al. The peptidoglycan of Mycobacterium abscessus is predominantly cross-linked by L, D-transpeptidases
Friedrich et al. Molecular analyses of the natural transformation machinery and identification of pilus structures in the extremely thermophilic bacterium Thermus thermophilus strain HB27
Coffey et al. Recombinational exchanges at the capsular polysaccharide biosynthetic locus lead to frequent serotype changes among natural isolates of Streptococcus pneumoniae
Novak et al. Penicillin tolerance genes of Streptococcus pneumoniae: the ABC‐type manganese permease complex Psa
Ogawa et al. Inhibition of Streptococcus mutans biofilm formation by Streptococcus salivarius FruA
Al‐Ghazzewi et al. Effect of konjac glucomannan hydrolysates and probiotics on the growth of the skin bacterium Propionibacterium acnes in vitro
BG102612A (en) Complementary adenoviral vector systems and cellular lines
Davies et al. Evolutionary genetics of Pasteurella haemolytica isolates recovered from cattle and sheep
MXPA04000808A (es) Cepas probioticas de lactobacillus salivarius.
SE9401806D0 (sv) Method and means for the production of hyaluronic acid
Albertí et al. Structure of the has operon promoter and regulation of hyaluronic acid capsule expression in group A Streptococcus
WO2001025254A3 (en) Novel adjuvant comprising a lipopolysaccharide antagonist
MA20545A1 (fr) Procede de preparation de souches de bacille thuringiensis presentant une activite amelioree a l'encontre de certains ravageurs du type l'epidoptere et nouvelle bouche ainsi preparee
AU4660893A (en) Deletion mutants as vaccines for cholera
Fujita et al. Biological functions of glucan‐binding protein B of Streptococcus mutans
HK1046929A1 (zh) 预防病原性细菌引起的腹泻的双歧杆菌
NO20005141L (no) Streptokokkpreparat
Fujiwara et al. Biochemical and genetic characterization of serologically untypable Streptococcus mutans strains isolated from patients with bacteremia
Bongaerts et al. Antigenicity, expression, and molecular characterization of surface-located pullulanase of Streptococcus pneumoniae
Takada et al. Streptococcus orisasini sp. nov. and Streptococcus dentasini sp. nov., isolated from the oral cavity of donkeys
Deng et al. Effects of the oral spirochete Treponema denticola on interleukin‐8 expression from epithelial cells
Igarashi et al. Inactivation of srtA gene of Streptococcus mutans inhibits dextran‐dependent aggregation by glucan‐binding protein C
Sato et al. gbpC and pac gene mutations detected in Streptococcus mutans strain GS‐5
WO2002064816A3 (en) Multiple determinants for metabolic phenotypes
Haenni et al. Mutational analysis of class A and class B penicillin-binding proteins in Streptococcus gordonii

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application